Table 1.
Clinical phenotype | Clinical observation | Patient |
||||||
---|---|---|---|---|---|---|---|---|
Vl:1 | VI:2 | VI:5 | VI:6 | VI:7 | VI:10 | VI:11 | ||
Age | Present age | 20 years | 24 years | 22 years | 18 years | 14 years | 16 years | 12 years |
| ||||||||
Epilepsy | Age of onset | 2.5 years | 3 years | 1.2 years | 2.5 years | 2 years | 1.8 years | 3.5 years |
|
||||||||
Types of seizures | Focal onset | Focal onset | Generalized tonic clonic | Focal onset | Focal onset | Focal onset aware | Generalized tonic clonic | |
|
||||||||
Treatment | Carbamazepine and lamotrigine | Carbamazepine and lamotrigine | Valproic acid and clonazepam | Carbamazepine and lamotrigine | Valproic acid, levetiracetam, clonazepam | Levetiracetam and carbamazepine | Carbamazepine and valproic acid | |
|
||||||||
Outcome | No | No | No | No | Under minor control | No | No | |
| ||||||||
Language impairment | Difficulty in receptive and expressive language | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
|
||||||||
Type of language impairment | SLI | SLI | SLI | SLI | SLI | SLI | SLI | |
| ||||||||
Obesity | Age of onset | 3.5 years | 4 years | 2.9 years | 3 years | 3.5 years | 4 years | 4.5 years |
|
||||||||
BMI (kg/m2/percentile) | 37 kg/m2 | 34.4 kg/m2 | 42 kg/m2 | 98th centile | 96th centile | 99th centile | 95th centile | |
| ||||||||
Observations at Birth | Delivery | Normal | Normal | Normal | Normal | Normal | Normal | Normal |
|
||||||||
Apgar scores | >7 | >7 | >7 | >7 | >7 | >7 | >7 | |
| ||||||||
Developmental milestones | Crawling | 12–15 months | 14–16 months | 12–15 months | 13–16 months | 12–15 months | 14–16 months | 14–16 months |
|
||||||||
Walking | 18–22 months | 20–24 months | 18–24 months | 18–24 months | 20–24 months | 20–24 months | 20–24 months | |
|
||||||||
Talking | 3—4 years | 3–4 years | 3–4 years | 3–4 years | 2.5–3 years | 3–4 years | 3–4 years |